Antonia Periclou

Summary

Affiliation: Forest Research Institute
Country: USA

Publications

  1. ncbi request reprint Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil
    Antonia P Periclou
    Clinical Pharmacology and Drug Dynamics, Forest Research Institute, Jersey City, NJ 07311 4994, USA
    Ann Pharmacother 38:1389-94. 2004
  2. ncbi request reprint Pharmacokinetic study of memantine in healthy and renally impaired subjects
    Antonia Periclou
    Forest Research Institute, Jersey City, NJ, USA
    Clin Pharmacol Ther 79:134-43. 2006
  3. doi request reprint Effects of milnacipran on cardiac repolarization in healthy participants
    Antonia Periclou
    Forest Research Institute, Harborside Financial Center, Plaza V, Jersey City, NJ 07311, USA
    J Clin Pharmacol 50:422-33. 2010

Detail Information

Publications3

  1. ncbi request reprint Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil
    Antonia P Periclou
    Clinical Pharmacology and Drug Dynamics, Forest Research Institute, Jersey City, NJ 07311 4994, USA
    Ann Pharmacother 38:1389-94. 2004
    ..Memantine, a low- to moderate-affinity, uncompetitive N-methyl-D-aspartate receptor antagonist, was approved in the US for treatment of moderate to severe Alzheimer's disease in October 2003...
  2. ncbi request reprint Pharmacokinetic study of memantine in healthy and renally impaired subjects
    Antonia Periclou
    Forest Research Institute, Jersey City, NJ, USA
    Clin Pharmacol Ther 79:134-43. 2006
    ..Our objective was to evaluate the pharmacokinetics of the Alzheimer's disease treatment memantine in subjects with normal and impaired renal function...
  3. doi request reprint Effects of milnacipran on cardiac repolarization in healthy participants
    Antonia Periclou
    Forest Research Institute, Harborside Financial Center, Plaza V, Jersey City, NJ 07311, USA
    J Clin Pharmacol 50:422-33. 2010
    ..9 ms (90% CI: -6.6 to 8.3). The results suggest that milnacipran would not significantly affect cardiac repolarization at clinically relevant therapeutic and supratherapeutic concentrations...